The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...